Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2005
12/21/2005CN1711091A The use of endoperoxides for the treatment of infections caused by flaviviridae, including hepatitis c, bovine viral diarrhea and classical swine fever virus
12/21/2005CN1711090A Combination of a nitrogen mustard analogue and imatinib for the treatment of chronic lymphocytic leukemia
12/21/2005CN1711089A Combination administration of an indolinone with a chemotherapeutic agent for cell proliferation disorders
12/21/2005CN1711088A Methods of treating cancer and related methods
12/21/2005CN1711087A Histone deacetylase inhibitors for the treatment of ocular neovascular or edematous disorders and diseases
12/21/2005CN1711086A Histone deacetylase inhibitors for treating degenerative diseases of the eye
12/21/2005CN1711085A Remedy for overactive bladder comprising acetic acid anilide derivative as the active ingredient
12/21/2005CN1711084A Substituted 4-alkoxyoxazol derivatives as PPAR agonists
12/21/2005CN1711083A Oral mucosa formulation and process for preparing the same
12/21/2005CN1711081A Proline derivatives having affinity for the calcium channel alpha-2-delta subunit
12/21/2005CN1711080A Combination comprising docetaxel and a CDK inhibitor
12/21/2005CN1711079A 3,5,3' -triiodothronine sulfate as thyromimetic agent and pharmaceutical formulations thereof
12/21/2005CN1711078A Methods of treating injuries of the nervous system associated with hemorrhage
12/21/2005CN1711077A Combination product for controlling insect pests
12/21/2005CN1711076A Combination cancer therapy with a GST-activated anticancer compound and another anticancer therapy
12/21/2005CN1709426A Capsule for treating hypertension and coronary disease and its preparing method
12/21/2005CN1709278A Chitosangynaecological suppository and its preparing method
12/21/2005CN1709277A Injection grifola frondosa beta-glucose lyophilized powder
12/21/2005CN1709276A Great burnet polysaccharide formulation, and its preparation method and use
12/21/2005CN1709275A Use of flavone substance or triterpene compound for treating thyreoidism
12/21/2005CN1709274A Novel use of medicinal formulation capable of improving cerebral metabolism for preventing and treating osteoporosis
12/21/2005CN1709273A Roxhthromycin soft capsule and its preparing method
12/21/2005CN1709272A Combined medicine of diammonium glycyrhetate and its preparing method
12/21/2005CN1709271A Method for preparing target magnetic nano drug for treating leucosis
12/21/2005CN1709270A Compound injection formulation compose dof borneol and pseudo-ginseng total saponin and its preparing method
12/21/2005CN1709269A Medicinal composition containing polydatin and its use
12/21/2005CN1709268A Adefovir dipivoxil orally disintegrating tablet and its preparing method
12/21/2005CN1709267A Polyenic phosphatidylcholine powder injection and its preparing method
12/21/2005CN1709266A Ointment for treating skin disease and its production method
12/21/2005CN1709265A Chinese medicine active ingredient composition for treating cardio-cerebrovascular diseases
12/21/2005CN1709264A Use of ganoderic acid T and ganoderic and Me in tumour growth or proliferation inhibitor
12/21/2005CN1709263A Antibiotic composition
12/21/2005CN1709262A Injection cefteram composition
12/21/2005CN1709261A Lornoxicam dropping pill and its preparing method
12/21/2005CN1709260A Prostatic atrophy antiphlogistic injection liquid
12/21/2005CN1709259A Use of NF-kB inhibitor for treating several diseases
12/21/2005CN1709258A Composition for treating hyperlipemia
12/21/2005CN1709257A Composition for treating hyperlipemia
12/21/2005CN1709256A Aripiprazole orally disintegrating tablet formulation and its preparing method
12/21/2005CN1709255A Antipyetics hydrogen chloride tilidine compound formulation
12/21/2005CN1709254A Use of cepharanthine for preparing HSV-II drug
12/21/2005CN1709253A Stable medicinal composition containing pitavastatin
12/21/2005CN1709252A Preparations of artemisinin or its derivatives and amodiaquine or its derivatives and preparation method thereof
12/21/2005CN1709251A Use of 1-deoxynojirimycin for preparing diabete and disney disease drug
12/21/2005CN1709250A Use of 2,2'-dipyridine N-oxide disulfur for preparing anti-tumor drug
12/21/2005CN1709249A Pioglitazone soft capsule and its preparing method
12/21/2005CN1709248A Lansoprazole lyophilized powder injection and its preparing method
12/21/2005CN1709247A Clnidipine dropping pill
12/21/2005CN1709246A Cilnidipine orally disintegrating tablet and its preparing method
12/21/2005CN1709245A Use of levo-ornidazole for preparing anti-parasitic-infectious drug
12/21/2005CN1709244A Vagina medicinal composition
12/21/2005CN1709243A Vagina medicine containing ebselen and its use
12/21/2005CN1709242A Glime piride soft capsule and its preparing method
12/21/2005CN1709241A Intravenous injection stable concertrated clear solution containing rifamycin after dilution
12/21/2005CN1709240A Line-implanted spot-removing liquid
12/21/2005CN1709239A Gingko lactone lyophilized powder for injection and its preparing method
12/21/2005CN1709238A Power for intravenous injection with liver-protecting action, and its preparation and quality control method
12/21/2005CN1709237A Chinese medicine preparation for treating hepatitis and its preparing method
12/21/2005CN1709236A Fat emulsion containing docetaxel and its preparing method
12/21/2005CN1709235A Acetic arginine injection liquid and its manufacturing method
12/21/2005CN1709234A Calcium-zinc gluconate oral liquid component and its process
12/21/2005CN1709233A Lyophiliced powder containing tiprenolol and its preparing method
12/21/2005CN1709232A Injection liposome microball containing ketoprofen or ketoprofen ester and its preparing process
12/21/2005CN1709231A Tolterodine tartrate soft capsule and its preparing method
12/21/2005CN1709230A Memantine hydrochloride dispersable table and its preparing method
12/21/2005CN1709229A Memantine hydrochloride orally disintegrating tablet and its preparing method
12/21/2005CN1709228A Curcumin solid dispersion, and its preparing method and use
12/21/2005CN1709227A Use of rheum emodin as peroxidase growth factor activated receptor gamma excitomotor
12/21/2005CN1232641C Modulator for function of receptor of TNF/NGF receptor family and other protein
12/21/2005CN1232539C Match of organic medicine and beta-cyclodextrin derivative and its preparing process
12/21/2005CN1232521C Novel crystal form of 9-substituted hypoxanthine derivatives
12/21/2005CN1232520C Salts of bicyclic N-acylated imidazo-3-amines and imidazo-5-amines
12/21/2005CN1232518C Bi-heterocyclic compounds with antitumour and chemosensitising activity
12/21/2005CN1232517C Anti-cancer active substance of cyathocline purpurea and separating and purifying method thereof
12/21/2005CN1232513C 1-[1-(hetero) aryl-1-perhydroxyalkylmethyl]-piperazine compound, preparation thereof and pharmaceutics containing it
12/21/2005CN1232511C Process for preparing oxazolyl acetate derivative and its salts
12/21/2005CN1232507C Growth hormone secretagogues
12/21/2005CN1232503C Propenecarboxylic acid amidoxime derivatives, process for preparation thereof, and pharmaceutical compositions containing same
12/21/2005CN1232303C Use of gene NMESI related to esophageal carcinoma and encoded polypeptide
12/21/2005CN1232302C Compound preparation of Azithromycin and Pidotimod
12/21/2005CN1232301C Compound preparation of valvciclovir HCL and Pidotimod
12/21/2005CN1232300C Left ofloxacin and Pidotimod compound preparation
12/21/2005CN1232277C Product containing extract of balsam pear and pumpkin possessing functions of reducing blood sugar
12/21/2005CN1232260C Application of fungus polysaccharide sulfate in the preparation of chronic nephritis and kidney failure treating medicine
12/21/2005CN1232259C Medicine composition with two-way immune regulation function by oral cavity local administration
12/21/2005CN1232258C Anti-infection medicine
12/21/2005CN1232257C Application of N-acetylglucosamine in the preparation of medicine for treating and controlling non specific inflammation due to physicochemical factor
12/21/2005CN1232256C Application of N-acetylglucosamine in preparation of medicine for treating local injure or whole body syndrome due to self immune reaction
12/21/2005CN1232255C Diabetes remedies
12/21/2005CN1232254C United slow release agent for preventing and treating piglet and rabbit coccidiosis and dysentery disease and its preparing method
12/21/2005CN1232253C Combined slow-release agent for preventing and treating domestic animal schistosome, fascioliasis, cestodiasis and nematodiasis disease and preparing method thereof
12/21/2005CN1232252C Retard release preparation containing alpha-lipoic acid (derivatives)
12/21/2005CN1232251C Gingko lactone powder injection and its preparation method
12/21/2005CN1232250C Andrographolide lactone microcapsule and its preparation method
12/21/2005CN1232249C Application of chalcone for preparing medicines for treating hepatitis
12/21/2005CN1232248C Combined sustained release agent and preparation thereof for preventing and treating livestock helminth, acarid and ectosarc disease
12/21/2005CN1232246C Application of 4-methyl cyclopentadecanone in manufacture of medicine
12/21/2005CA2510220A1 Heparin barrier coating for controlled drug release
12/20/2005US6977302 useful in treatment of fungal infections in humans and other mammals
12/20/2005US6977298 Tricyclic inhibitors of poly(ADP-ribose) polymerases
1 ... 4429 4430 4431 4432 4433 4434 4435 4436 4437 4438 4439 4440 4441 4442 4443 4444 4445 4446 4447 4448 4449 ... 7860